Carlos Blondel
About
Carlos is a biochemist from Universidad de Chile, the same place where he obtained his PhD in 2011 working under the mentorship of Dr. Inés Contreras studying both the regulation of LPS biosynthesis and the identification of Type VI Secretion Systems in Salmonella under the mentorship of Dr. Carlos Santiviago. In 2013, he was named PEW Latin American Fellow in the Biomedical Sciences and he joined the laboratory of HHMI Investigator Dr. Matthew K. Waldor at Harvard Medical School and Brigham and Women´s Hospital for his postdoctoral training. During his postdoctoral training under Dr. Waldor´s mentorship, he studied the molecular mechanisms that underlie the virulence of bacterial pathogens such as Vibrio parahaemolyticus and Escherichia coli O157:H7 and he utilized CRISPR/Cas9-based genetic screens to identify host factors that promote human susceptibility to the toxic action of Vibrio parahaemolyticus' two Type III Secretion Systems (T3SS). In 2017 he was named HHMI-Gulbenkian International Reserch Scholar (2017-2022). His lab is currently at the Institute of Biomedical Sciences of Universidad Andres Bello, Chile.